223 related articles for article (PubMed ID: 7760096)
1. Amplification and differential expression of members of the erbB-gene family in human glioblastoma.
Schlegel J; Stumm G; Brändle K; Merdes A; Mechtersheimer G; Hynes NE; Kiessling M
J Neurooncol; 1994; 22(3):201-7. PubMed ID: 7760096
[TBL] [Abstract][Full Text] [Related]
2. Molecular analysis of the erbB gene family calmodulin-binding and calmodulin-like domains in astrocytic gliomas.
Arjona D; Bello MJ; Alonso ME; Gonzalez-Gomez P; Lomas J; Aminoso C; Lopez-Marin I; Isla A; De Campos JM; Vaquero J; Gutierrez M; Villalobo A; Rey JA
Int J Oncol; 2004 Nov; 25(5):1489-94. PubMed ID: 15492843
[TBL] [Abstract][Full Text] [Related]
3. Amplification of the epidermal-growth-factor-receptor gene correlates with different growth behaviour in human glioblastoma.
Schlegel J; Merdes A; Stumm G; Albert FK; Forsting M; Hynes N; Kiessling M
Int J Cancer; 1994 Jan; 56(1):72-7. PubMed ID: 8262681
[TBL] [Abstract][Full Text] [Related]
4. Expression of neu/c-erbB-2 in human brain tumors.
Schwechheimer K; Läufle RM; Schmahl W; Knödlseder M; Fischer H; Höfler H
Hum Pathol; 1994 Aug; 25(8):772-80. PubMed ID: 7914508
[TBL] [Abstract][Full Text] [Related]
5. Differential amplification of the TGF-alpha gene in human gliomas.
Yung WK; Zhang X; Steck PA; Hung MC
Cancer Commun; 1990; 2(6):201-5. PubMed ID: 2165797
[TBL] [Abstract][Full Text] [Related]
6. Differential distribution of erbB receptors in human glioblastoma multiforme: expression of erbB3 in CD133-positive putative cancer stem cells.
Duhem-Tonnelle V; Bièche I; Vacher S; Loyens A; Maurage CA; Collier F; Baroncini M; Blond S; Prevot V; Sharif A
J Neuropathol Exp Neurol; 2010 Jun; 69(6):606-22. PubMed ID: 20467331
[TBL] [Abstract][Full Text] [Related]
7. Expression of the epidermal growth factor receptor in astrocytic tumours is specifically associated with glioblastoma multiforme.
Agosti RM; Leuthold M; Gullick WJ; Yasargil MG; Wiestler OD
Virchows Arch A Pathol Anat Histopathol; 1992; 420(4):321-5. PubMed ID: 1314448
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of EGFRvIII in high malignancy grade astrocytomas and evaluation of prognostic significance.
Aldape KD; Ballman K; Furth A; Buckner JC; Giannini C; Burger PC; Scheithauer BW; Jenkins RB; James CD
J Neuropathol Exp Neurol; 2004 Jul; 63(7):700-7. PubMed ID: 15290895
[TBL] [Abstract][Full Text] [Related]
9. c-erbB-2 in astrocytomas: infrequent overexpression by immunohistochemistry and absence of gene amplification by fluorescence in situ hybridization.
Haapasalo H; Hyytinen E; Sallinen P; Helin H; Kallioniemi OP; Isola J
Br J Cancer; 1996 Mar; 73(5):620-3. PubMed ID: 8605096
[TBL] [Abstract][Full Text] [Related]
10. Coexpression of epidermal growth factor receptor protein and c-erbB-2 oncoprotein in human astrocytic tumors. An immunohistochemical study.
Dietzmann K; von Bossanyi P
Zentralbl Pathol; 1994 Nov; 140(4-5):335-41. PubMed ID: 7826981
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas.
Watanabe K; Tachibana O; Sata K; Yonekawa Y; Kleihues P; Ohgaki H
Brain Pathol; 1996 Jul; 6(3):217-23; discussion 23-4. PubMed ID: 8864278
[TBL] [Abstract][Full Text] [Related]
12. Spontaneous activation and signaling by overexpressed epidermal growth factor receptors in glioblastoma cells.
Thomas CY; Chouinard M; Cox M; Parsons S; Stallings-Mann M; Garcia R; Jove R; Wharen R
Int J Cancer; 2003 Mar; 104(1):19-27. PubMed ID: 12532415
[TBL] [Abstract][Full Text] [Related]
13. Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme.
Giannini C; Sarkaria JN; Saito A; Uhm JH; Galanis E; Carlson BL; Schroeder MA; James CD
Neuro Oncol; 2005 Apr; 7(2):164-76. PubMed ID: 15831234
[TBL] [Abstract][Full Text] [Related]
14. p53 mutations versus EGF receptor expression in giant cell glioblastomas.
Peraud A; Watanabe K; Plate KH; Yonekawa Y; Kleihues P; Ohgaki H
J Neuropathol Exp Neurol; 1997 Nov; 56(11):1236-41. PubMed ID: 9370234
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme.
Shinojima N; Tada K; Shiraishi S; Kamiryo T; Kochi M; Nakamura H; Makino K; Saya H; Hirano H; Kuratsu J; Oka K; Ishimaru Y; Ushio Y
Cancer Res; 2003 Oct; 63(20):6962-70. PubMed ID: 14583498
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of c-erbB2 is a negative prognostic factor in anaplastic astrocytomas.
Gulati S; Ytterhus B; Granli US; Gulati M; Lydersen S; Torp SH
Diagn Pathol; 2010 Mar; 5():18. PubMed ID: 20331873
[TBL] [Abstract][Full Text] [Related]
17. Epidermal growth factor receptor family (EGFR, ErbB2-4) in gliomas and meningiomas.
Andersson U; Guo D; Malmer B; Bergenheim AT; Brännström T; Hedman H; Henriksson R
Acta Neuropathol; 2004 Aug; 108(2):135-42. PubMed ID: 15148612
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor receptor gene amplification and protein expression in glioblastoma multiforme: prognostic significance and relationship to other prognostic factors.
Layfield LJ; Willmore C; Tripp S; Jones C; Jensen RL
Appl Immunohistochem Mol Morphol; 2006 Mar; 14(1):91-6. PubMed ID: 16540738
[TBL] [Abstract][Full Text] [Related]
19. Survival of patients with glioblastoma multiforme is not influenced by altered expression of p16, p53, EGFR, MDM2 or Bcl-2 genes.
Newcomb EW; Cohen H; Lee SR; Bhalla SK; Bloom J; Hayes RL; Miller DC
Brain Pathol; 1998 Oct; 8(4):655-67. PubMed ID: 9804374
[TBL] [Abstract][Full Text] [Related]
20. Primary glioblastomas with and without EGFR amplification: relationship to genetic alterations and clinicopathological features.
Benito R; Gil-Benso R; Quilis V; Perez M; Gregori-Romero M; Roldan P; Gonzalez-Darder J; Cerdá-Nicolas M; Lopez-Gines C
Neuropathology; 2010 Aug; 30(4):392-400. PubMed ID: 20051017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
